Modulation of the Electrophysiologic Actions of E-4031 and Dofetilide by Hyperkalemia and Acidosis in Rabbit Ventricular Myocytes
- 1 September 1997
- journal article
- Published by SAGE Publications in Journal of Cardiovascular Pharmacology and Therapeutics
- Vol. 2 (3) , 205-212
- https://doi.org/10.1177/107424849700200307
Abstract
Background: E-4031 and dofetilide are new class III antiarrhythmic agents that inhibit the rapid component of the delayed rectifier potassium channel (IKr); however, the effectiveness of many antiarrhythmic drugs in ischemic conditions is uncertain. Methods and Results: We modeled two components of ischemia, hyperkalemia (9.6 mM) and acidosis (pH 6.8), in voltage-clamped single rabbit ventricular myocytes to help deter mine the effect of ischemia on the action of these two drugs. In physiologic solution both E- 4031 and dofetilide blocked IKr and significantly reduced total outward current. In hyper kalemic solution, both E-4031 and dofetilide showed significantly reduced blockade of IKr, while in acidotic solution dofetilide showed significantly reduced blockade of IKr and E-4031 showed a trend to reduced blockade. Neither drug significantly reduced total outward current in hyperkalemic or acidotic solutions. Conclusions: In these conditions, E-4031 and dofetilide demonstrate reduced blockade of I Kr, resulting in loss of class III effect. Furthermore, the complete loss of blocking effect on total outward current during simulated ischemia suggests increases of other repolarizing cur rents also contribute to loss of class III effect.This publication has 31 references indexed in Scilit:
- Comparative Effects of Increased Extracellular Potassium and Pacing Frequency on the Class III Activities of Methanesulfonanilide IKr Blockers Dofetilide, d-Sotalol, E-4031, and MK-499Journal of Cardiovascular Pharmacology, 1994
- Comparison of the Cardiac Electrophysiologic Effects of NE-10064 with Sotalol and E-4031 and Their Modification by Simulated IschaemiaJournal of Cardiovascular Pharmacology, 1994
- Dofetilide, A Novel Class III Antiarrhythmic AgentJournal of Cardiovascular Pharmacology, 1992
- Electromechanical Action of Dofetilide and D-Sotalol During Simulated Metabolic Acidosis in Isolated Guinea Pig Ventricular MuscleJournal of Cardiovascular Pharmacology, 1992
- Effects of New and Potent Methanesulfonanilide Class III Antiarrhythmic Agents on Myocardial Refractoriness and Contractility in Isolated Cardiac MuscleJournal of Cardiovascular Pharmacology, 1991
- Limited effect of class III agents against acute ischaemic arrhythmias in anaesthetised catsJournal of Molecular and Cellular Cardiology, 1991
- Electrophysiology and Antiarrhythmic Actions of E-4031 in the Experimental Animal Model of Sudden Coronary DeathJournal of Cardiovascular Pharmacology, 1991
- Influence of ATP-sensitive potassium channel modulators on ischemia-induced fibrillation in isolated rat heartsJournal of Molecular and Cellular Cardiology, 1989
- Editorial: Modification of class III anti-arrhythmic activity in abnormal myocardiumCardiovascular Research, 1988
- Effects of sotalol on arrhythmias and electrophysiology during myocardial ischaemia and reperfusionCardiovascular Research, 1984